GO:0007416 Synaptogenesis |
|
|
NRCAM
|
NM_001037133/NM_005010/NM_001037132
|
Neuronal cell adhesion molecule isoforms C, B, and A |
PCDHB10
|
NM_018930 |
Protocadherin β 10 precursor |
PCDHB16
|
NM_020957 |
Protocadherin β 16 precursor |
PCDHB9
|
NM_019119 |
Protocadherin β 9 precursor |
GO:0043406 Positive regulation of MAP kinase activity |
|
|
ADRB2
|
NM_000024 |
Adrenergic, β-2-, receptor, surface |
CXCR4
|
NM_001008540/NM_003467
|
Chemokine (C-X-C motif) receptor 4 isoforms a and b |
MADD
|
NM_003682/NM_130471/NM_130472/NM_130474/NM_130470/NM_130473/NM_130475/NM_130476/NM_001135943/NM_001135944
|
MAP-kinase activating death domain-containing |
MAP3K5
|
NM_005923 |
Mitogen-activated protein kinase kinase kinase |
PAK1
|
NM_002576/NM_001128620
|
p21-Activated kinase 1 isoforms 1 and 2 |
PROK2
|
NM_021935/NM_001126128
|
Prokineticin 2 isoforms a and b precursor |
TNF
|
NM_000594 |
Tumor necrosis factor α |
GO:0000187 Activation of MAPK activity |
|
|
ADRB2
|
NM_000024 |
Adrenergic, β-2-, receptor, surface |
CXCR4
|
NM_001008540/NM_003467
|
Chemokine (C-X-C motif) receptor 4 isoforms a and b |
MADD
|
NM_003682/NM_130471/NM_130472/NM_130474/NM_130470/NM_130473/NM_130475/NM_130476/NM_001135943/NM_001135944
|
MAP-kinase activating death domain-containing |
MAP3K5
|
NM_005923 |
Mitogen-activated protein kinase kinase kinase |
PROK2
|
NM_021935/NM_001126128
|
Prokineticin 2 isoforms a and b precursor |
TNF
|
NM_000594 |
Tumor necrosis factor α |